Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Levin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the Mississippi State Medical Association|November 22, 2005
KatrinaPhilip Levin
Anesthesiology|May 1, 2002
Recurrent pulmonary embolism during liver transplantation: possible role of hepatitis B immune globulin as a causative agentWeng H Wong, Michelle Braunfeld, Philip Levin
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Journal of Critical Care|May 22, 2023
Psychiatric patients' intensive care admission characteristics, weaning from mechanical ventilation and sedative drug use: A single center retrospective case-control studyNevo Barel, Tali Bdolach-Abraham, Philip Levin, et al.
Current Medical Research and Opinion|February 4, 2018
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record dataKathleen Lang, Hiep Nguyen, Huan Huang, et al.
Journal of Anesthesia, Analgesia and Critical Care|June 29, 2023
Intellectually disabled patients' intensive care admission characteristics, weaning from mechanical ventilation, and sedative drug use: a single-center retrospective case-control studyNoa Bineth, Nevo Barel, Tali Bdolah-Abram, et al.
Current Medical Research and Opinion|January 6, 2012
Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetesPhilip Levin, Wenhui Wei, Li Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2017
COMPARING CLINICAL OUTCOMES AND COSTS FOR DIFFERENT TREATMENT INTENSIFICATION APPROACHES IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN: ADDING GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS VERSUS ADDING RAPID-ACTING INSULIN OR INCREASING BASAL INSULIN DOSEPhilip Levin, Tao Fan, Xue Song, et al.
Clinical Therapeutics|December 19, 2015
Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes DrugsPhilip Levin, Steve Zhou, Emily Durden, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 23, 2015
DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTINGJay Lin, Steve Zhou, Wenhui Wei, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the Mississippi State Medical Association|November 22, 2005
KatrinaPhilip Levin
Anesthesiology|May 1, 2002
Recurrent pulmonary embolism during liver transplantation: possible role of hepatitis B immune globulin as a causative agentWeng H Wong, Michelle Braunfeld, Philip Levin
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Journal of Critical Care|May 22, 2023
Psychiatric patients' intensive care admission characteristics, weaning from mechanical ventilation and sedative drug use: A single center retrospective case-control studyNevo Barel, Tali Bdolach-Abraham, Philip Levin, et al.
Current Medical Research and Opinion|February 4, 2018
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record dataKathleen Lang, Hiep Nguyen, Huan Huang, et al.
Journal of Anesthesia, Analgesia and Critical Care|June 29, 2023
Intellectually disabled patients' intensive care admission characteristics, weaning from mechanical ventilation, and sedative drug use: a single-center retrospective case-control studyNoa Bineth, Nevo Barel, Tali Bdolah-Abram, et al.
Current Medical Research and Opinion|January 6, 2012
Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetesPhilip Levin, Wenhui Wei, Li Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2017
COMPARING CLINICAL OUTCOMES AND COSTS FOR DIFFERENT TREATMENT INTENSIFICATION APPROACHES IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN: ADDING GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS VERSUS ADDING RAPID-ACTING INSULIN OR INCREASING BASAL INSULIN DOSEPhilip Levin, Tao Fan, Xue Song, et al.
Clinical Therapeutics|December 19, 2015
Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes DrugsPhilip Levin, Steve Zhou, Emily Durden, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 23, 2015
DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTINGJay Lin, Steve Zhou, Wenhui Wei, et al.
Pageof 2